Every reference with a DOI in the deposited reference list resolved to a known
work in Crossref or DataCite at the dated check, and none carried a retraction,
withdrawal, or removal notice.
The 34 checked references that resolve
resolves10.2215/CJN.03670807Emerging Biomarkers for Evaluating Cardiovascular Risk in the Chronic Kidney Disease Patient
resolves10.1371/journal.pone.0131707The Addition of Vascular Calcification Scores to Traditional Risk Factors Improves Cardiovascular Risk Assessment in Patients with Chronic Kidney Disease
resolves10.2215/CJN.02190507Progressive Vascular Calcification over 2 Years Is Associated with Arterial Stiffening and Increased Mortality in Patients with Stages 4 and 5 Chronic Kidney Disease
resolves10.1074/jbc.M800021200Oxidative Stress Induces Vascular Calcification through Modulation of the Osteogenic Transcription Factor Runx2 by AKT Signaling
resolves10.1007/s00223-009-9297-8Elastin Degradation Accelerates Phosphate-Induced Mineralization of Vascular Smooth Muscle Cells
resolves10.1016/j.ajpath.2010.10.006Elastin Degradation and Vascular Smooth Muscle Cell Phenotype Change Precede Cell Loss and Arterial Medial Calcification in a Uremic Mouse Model of Chronic Kidney Disease
resolves10.1093/ndt/14.3.597Human recombinant erythropoietin inhibits interleukin-1 -stimulated nitric oxide and cyclic guanosine monophosphate production in cultured rat vascular smooth-muscle cells
resolves10.1152/ajpcell.00143.2002Modulation of the erythropoietin-induced proliferative pathway by cAMP in vascular smooth muscle cells
resolves10.1093/cvr/27.7.1233Erythropoietin increases cytosolic free calcium concentration in vascular smooth muscle cells
resolves10.1089/ten.tec.2014.0643Dual Delivery of EPO and BMP2 from a Novel Modular Poly-ɛ-Caprolactone Construct to Increase the Bone Formation in Prefabricated Bone Flaps
resolves10.1053/j.ajkd.2012.07.014Dose of Erythropoiesis-Stimulating Agents and Adverse Outcomes in CKD: A Metaregression Analysis
resolves10.1038/ki.2008.295Secondary analysis of the CHOIR trial epoetin-α dose and achieved hemoglobin outcomes
resolves10.1111/bph.12672<scp>JAK2/STAT5/Bcl‐xL</scp> signalling is essential for erythropoietin‐mediated protection against apoptosis induced in <scp>PC</scp>12 cells by the amyloid β−peptide <scp>Aβ<sub>25–35</sub></scp>
resolves10.1172/JCI117205TGF-beta 1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify.
resolves10.1161/01.RES.81.4.600Angiotensin II–Induced Stimulation of Smooth Muscle α-Actin Expression by Serum Response Factor and the Homeodomain Transcription Factor MHox
resolves10.1074/jbc.M504774200Transforming Growth Factor-β1-induced Expression of Smooth Muscle Marker Genes Involves Activation of PKN and p38 MAPK
resolves10.1038/ki.2012.40Activation of nuclear factor-kappa B accelerates vascular calcification by inhibiting ankylosis protein homolog expression
resolves10.1038/ki.2011.18Mitochondrial reactive oxygen species promote p65 nuclear translocation mediating high-phosphate-induced vascular calcification in vitro and in vivo
resolves10.1038/35088074Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-κB signalling cascades
checked 2026-07-23 — re-checked daily as this page is visited;
titles and statuses come from Crossref and DataCite and are not part of the signed record
Both snippets point at the live badge image and link back to this page. The
badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.